Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Sales | 2,500 | 165,000 | 0 | 0 | 0 |
| Gross Profit | 2,500 | 165,000 | N/A | N/A | N/A |
| Operating Expenses | 26,729 | 25,445 | 28,014 | 0 | 0 |
| Operating Income | -24,229 | 139,555 | -28,014 | N/A | N/A |
| Other Income | -802 | 1,227 | -4,480 | 0 | 0 |
| Pre-tax Income | -25,031 | 140,782 | -32,494 | 0 | 0 |
| Income Tax | -279 | 1,726 | N/A | N/A | N/A |
| Net Income Continuous | -24,752 | 139,056 | -32,494 | N/A | N/A |
| Net Income | $-24,752 | $139,056 | $-32,494 | $N/A | $N/A |
| EPS Basic Total Ops | -10.25 | 5.92 | -13.91 | N/A | N/A |
| EPS Basic Continuous Ops | -10.25 | 58.21 | -13.90 | N/A | N/A |
| EPS Diluted Total Ops | -10.25 | 3.22 | -13.91 | N/A | N/A |
| EPS Diluted Continuous Ops | -10.25 | 32.23 | -13.90 | N/A | N/A |
| EBITDA(a) | $-23,441 | $140,409 | $-27,064 | $N/A | $N/A |